Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 4
2014 1
2016 1
2018 5
2019 6
2020 9
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Peptide vaccines for hematological malignancies: a missed promise?
Bocchia M, Defina M, Aprile L, Sicuranza A. Bocchia M, et al. Among authors: sicuranza a. Int J Hematol. 2014 Feb;99(2):107-16. doi: 10.1007/s12185-013-1497-3. Epub 2014 Jan 8. Int J Hematol. 2014. PMID: 24399190 Free article. Review.
CD26/DPP-4 in Chronic Myeloid Leukemia.
Sicuranza A, Raspadori D, Bocchia M. Sicuranza A, et al. Cancers (Basel). 2022 Feb 11;14(4):891. doi: 10.3390/cancers14040891. Cancers (Basel). 2022. PMID: 35205639 Free PMC article. Review.
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients.
Gozzetti A, Bacchiarri F, Sammartano V, Defina M, Sicuranza A, Mecacci B, Zappone E, Cencini E, Fabbri A, Raspadori D, Bocchia M. Gozzetti A, et al. Among authors: sicuranza a. Front Oncol. 2020 Dec 21;10:570187. doi: 10.3389/fonc.2020.570187. eCollection 2020. Front Oncol. 2020. PMID: 33415072 Free PMC article.
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose.
Fiorino F, Sicuranza A, Ciabattini A, Santoni A, Pastore G, Simoncelli M, Polvere J, Galimberti S, Auddino S, Baratè C, Montagnani F, Sammartano V, Bocchia M, Medaglini D. Fiorino F, et al. Among authors: sicuranza a. Biomedicines. 2021 Oct 15;9(10):1480. doi: 10.3390/biomedicines9101480. Biomedicines. 2021. PMID: 34680595 Free PMC article.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Caocci G, Mulas O, Capodanno I, Bonifacio M, Annunziata M, Galimberti S, Luciano L, Tiribelli M, Martino B, Castagnetti F, Binotto G, Pregno P, Stagno F, Abruzzese E, Bocchia M, Gozzini A, Albano F, Fozza C, Luzi D, Efficace F, Simula MP, Scaffidi L, Baratè C, De Gregorio F, Stella R, Gugliotta G, Pirillo F, Trawinska MM, Sicuranza A, Cattaneo D, Attolico I, Scalzulli E, Iurlo A, Foà R, Breccia M, La Nasa G. Caocci G, et al. Among authors: sicuranza a. Ann Hematol. 2021 Aug;100(8):2005-2014. doi: 10.1007/s00277-020-04392-w. Epub 2021 Jan 3. Ann Hematol. 2021. PMID: 33388860
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib.
Mulas O, Caocci G, Annunziata M, Martino B, Luciano L, Castagnetti F, Pregno P, Galimberti S, Albano F, Orlandi EM, Sgherza N, Iurlo A, Bonifacio M, Binotto G, Gozzini A, Bocchia M, Abruzzese E, Fozza C, Simula MP, De Gregorio F, Gugliotta G, Pirillo F, Baratè C, Attolico I, Elena C, Cattaneo D, Scaffidi L, Sicuranza A, Trawinska MM, Scalzulli E, Foà R, Breccia M, La Nasa G. Mulas O, et al. Among authors: sicuranza a. Hematol Oncol. 2020 Oct;38(4):607-610. doi: 10.1002/hon.2765. Epub 2020 Jul 23. Hematol Oncol. 2020. PMID: 32602167 No abstract available.
33 results